Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sesen Bio (SESN – Research Report) and Amphastar Pharmaceuticals (AMPH – Research Report). Sesen Bio (SESN) Canaccord Genuity analyst John Newman maintained a

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sesen Bio (SESN – Research Report) and Arena Pharma (ARNA – Research Report) with bullish sentiments. Sesen Bio (SESN) Canaccord Genuity analyst

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Monday at $1.12. According to TipRanks.com, Newman is a 5-star analyst

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $1.29. According to TipRanks.com, Newman is

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Monday at $1.06. According to TipRanks.com, Newman is

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Tuesday at $0.69, close to its 52-week low of $0.37. According